HK1205264A1 - Method for monitoring hiv specific t cell responses - Google Patents

Method for monitoring hiv specific t cell responses Download PDF

Info

Publication number
HK1205264A1
HK1205264A1 HK15105947.6A HK15105947A HK1205264A1 HK 1205264 A1 HK1205264 A1 HK 1205264A1 HK 15105947 A HK15105947 A HK 15105947A HK 1205264 A1 HK1205264 A1 HK 1205264A1
Authority
HK
Hong Kong
Prior art keywords
cell responses
hiv specific
monitoring hiv
monitoring
hiv
Prior art date
Application number
HK15105947.6A
Other languages
English (en)
Chinese (zh)
Inventor
Marta RUIZ RIOL
Christian Brander
Javier IBARRONDO
Original Assignee
Laboratorios Del Dr. Esteve, S.A.
Fundació Privada Institut De Recerca De La Sida-Caixa
Institució Catalana De Recerca I Estudis Avançats
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Del Dr. Esteve, S.A., Fundació Privada Institut De Recerca De La Sida-Caixa, Institució Catalana De Recerca I Estudis Avançats filed Critical Laboratorios Del Dr. Esteve, S.A.
Publication of HK1205264A1 publication Critical patent/HK1205264A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/525—Tumor necrosis factor [TNF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/555—Interferons [IFN]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK15105947.6A 2012-03-23 2013-03-22 Method for monitoring hiv specific t cell responses HK1205264A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261615038P 2012-03-23 2012-03-23
EP12382109.2 2012-03-23
EP12382109 2012-03-23
US61/615,038 2012-03-23
PCT/EP2013/056110 WO2013139972A1 (en) 2012-03-23 2013-03-22 Method for monitoring hiv specific t cell responses

Publications (1)

Publication Number Publication Date
HK1205264A1 true HK1205264A1 (en) 2015-12-11

Family

ID=49221879

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15105947.6A HK1205264A1 (en) 2012-03-23 2013-03-22 Method for monitoring hiv specific t cell responses

Country Status (9)

Country Link
US (1) US9709577B2 (enExample)
EP (1) EP2828656B1 (enExample)
JP (1) JP6272820B2 (enExample)
CN (1) CN104272108A (enExample)
CA (1) CA2868066C (enExample)
HK (1) HK1205264A1 (enExample)
IN (1) IN2014DN08394A (enExample)
MX (1) MX2014011484A (enExample)
WO (1) WO2013139972A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101777256B1 (ko) 2016-07-07 2017-09-12 대한민국(농림축산식품부 농림축산검역본부장) T 세포의 병원체 감염 세포 독성능 평가 방법
KR101777252B1 (ko) 2016-07-07 2017-09-12 대한민국(농림축산식품부 농림축산검역본부장) T 세포의 prrsv 증식 억제능 평가 방법
CN110308285B (zh) * 2019-07-12 2022-07-26 中国人民解放军军事科学院军事医学研究院 用于预测重度电离辐射损伤死亡的标志物组合
CA3255609A1 (en) * 2022-03-09 2023-09-14 Institucio Catalana De Recerca I Estudis Avanqats AMPLIFIED IMMUNE MONITORING METHODS FOR ANALYZING ANTIGEN-SPECIFIC T LYMPHOCYTE RESPONSES
CN115754303A (zh) * 2022-11-24 2023-03-07 复旦大学附属华山医院 基于Th1和Th2细胞因子组合的评价方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9624456D0 (en) * 1996-11-25 1997-01-15 Isis Innovation Assay method
HK1044040A1 (zh) * 1998-11-16 2002-10-04 德克萨斯州立大学董事会 Hiv-特异的t-细胞诱导
AU2002952548A0 (en) * 2002-11-08 2002-11-21 Cellestis Limited Diagnostic assay
WO2005017192A2 (en) * 2003-08-14 2005-02-24 The General Hospital Corporation Screening for gestational disorders
EP1767937A1 (en) * 2005-09-27 2007-03-28 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method of diagnosis of tuberculosis related immune restoration syndrome (IRS)
ATE476656T1 (de) * 2006-03-20 2010-08-15 St Vincents Hosp Sydney Verfahren zum nachweis antigenspezifischer oder mitogenaktivierter t-zellen
WO2008127840A2 (en) * 2007-03-22 2008-10-23 University Of Iowa Research Foundation Flavivirus ns5a proteins for the treatment of hiv
US20090263828A1 (en) * 2008-04-16 2009-10-22 Franco Lori Novel assay for precursor T-cells having high proliferative capacity (PHPC-asay)
WO2010037408A1 (en) * 2008-09-30 2010-04-08 Curevac Gmbh Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
KR20140041505A (ko) * 2011-04-29 2014-04-04 셀렉타 바이오사이언시즈, 인크. 조절 b 세포 유도를 위한 관용원성 합성 나노운반체

Also Published As

Publication number Publication date
EP2828656A1 (en) 2015-01-28
CA2868066C (en) 2019-11-12
WO2013139972A1 (en) 2013-09-26
MX2014011484A (es) 2015-09-23
CN104272108A (zh) 2015-01-07
US20150057175A1 (en) 2015-02-26
IN2014DN08394A (enExample) 2015-05-08
JP2015513100A (ja) 2015-04-30
CA2868066A1 (en) 2013-09-26
EP2828656B1 (en) 2019-09-18
JP6272820B2 (ja) 2018-01-31
US9709577B2 (en) 2017-07-18

Similar Documents

Publication Publication Date Title
EP3775706A4 (en) Medical residential and laboratory uses of purified air
WO2013130274A3 (en) Aluminum alloy with additions of scandium, zirconium and erbium
MX2018004206A (es) Metodos para diagnosticar enfermedades infecciosas utilizando medios de adsorcion.
WO2015114506A3 (en) Biosensors for the detection of infection and associated maladies
EP3608021A3 (en) Analyte detection devices, multiplex and tabletop devices for detection of analytes, and uses thereof
IN2014DN08394A (enExample)
EP2825298A4 (en) MIXTURES OF SULFONED BLOCK COPOLYMERS AND PARTICLE CARBON AND MEMBRANES, FILMS AND COATINGS THEREWITH
EP3066236A4 (en) Cell-free nucleic acids for the analysis of the human microbiome and components thereof
EP2425792A3 (en) An electrosurgical instrument
EP4410315A3 (en) Anti-cd3 antibodies and methods of use
EP3107181A3 (en) Monitoring device for secondary battery, battery pack, and protection system for secondary battery
EP2775162A3 (en) Composite bead plate and an air spring using the same
WO2012024194A3 (en) Microfluidic cell separation in the assay of blood
WO2016089453A8 (en) Debye length modulation
WO2013164281A3 (en) Systems and methods for performing correlation analysis on clinical outcome and characteristics of biological tissue
EP3522570A3 (en) Spatial audio signal filtering
EP2991766A4 (en) Bodily fluid specimen collection and assay device
EP2653194A3 (en) Adjustable low pressure warning device
WO2016188430A8 (en) Devices and methods for sample collection
WO2015019342A3 (en) Application selecting device coupled to operate with a smart-phone connector and methods of use thereof
WO2020069513A3 (en) Dianostic lighting device
EP3134736A4 (en) Use of interleukin-2 for diagnosis of celiac disease
HK1190565A2 (en) Shower caddy clamp
WO2014023984A3 (en) Method for the direct detection of mycobacterium tuberculosis
EP2927046A3 (en) Protection system against reverse battery connection